Allogene Therapeutics, Inc.

MACQUARIE GROUP LTD ALLO

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/13/2025

Shares

146,779

Value ($000)

182

Weight

0.0%

2019 Q4 - 2025 Q3 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/13/2025	182	0.0%	146,779	9/30/2025
2025 Q1	5/15/2025	214	0.0%	146,779	3/31/2025
2024 Q4	2/14/2025	313	0.0%	146,779	12/31/2024
2024 Q3	11/14/2024	411	0.0%	146,779	9/30/2024
2024 Q2	8/9/2024	342	0.0%	146,779	6/30/2024
2024 Q1	5/14/2024	656	0.0%	146,779	3/31/2024
2023 Q4	2/14/2024	471	0.0%	146,779	12/31/2023
2023 Q3	11/14/2023	465	0.0%	146,779	9/30/2023
2023 Q2	10/27/2023	729	0.0%	146,779	6/30/2023
2023 Q1	6/1/2023	725	0.0%	146,779	3/31/2023
2022 Q4	2/21/2023	923	0.0%	146,779	12/31/2022
2022 Q3	11/14/2022	1,603	0.0%	147,372	9/30/2022
2022 Q2	8/17/2022	1,692	0.0%	148,469	6/30/2022
2022 Q1	5/16/2022	1,352	0.0%	148,469	3/31/2022
2021 Q4	2/11/2022	2,215	0.0%	148,469	12/31/2021
2021 Q3	11/12/2021	3,812	0.0%	148,329	9/30/2021
2021 Q2	8/13/2021	3,868	0.0%	148,329	6/30/2021
2021 Q1	5/14/2021	5,236	0.0%	148,329	3/31/2021
2020 Q4	2/16/2021	3,756	0.0%	148,783	12/31/2020
2020 Q3	11/13/2020	5,611	0.0%	148,783	9/30/2020
2020 Q2	8/11/2020	6,371	0.0%	148,783	6/30/2020
2020 Q1	5/15/2020	2,853	0.0%	146,779	3/31/2020
2019 Q4	3/18/2020	3,813	0.0%	146,779	12/31/2019